Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Partnerships and Commissions
Toggle Search Area
Toggle Menu
e-mail Print Share
Oral Health Topics

Anticoagulant and Antiplatelet Medications and Dental Procedures

Key Points

There is both a growing number of individuals prescribed anticoagulation or antiplatelet therapy, as well as medications for this purpose. There is strong evidence for the older medications, as well as limited evidence for the new medications that, for most patients, it is not necessary to alter anticoagulation or antiplatelet therapy prior to dental intervention.

Drug Class Drug Names
  • warfarin (Coumadin®)
Antiplatelet agents*
  • clopidogrel (Plavix®)
  • ticlopidine (Ticlid®)
  • prasugrel (Effient®)
  • ticagrelor (Brilinta®)
  • aspirin
Target-specific oral anticoagulants**
  • dabigatran (Pradaxa®)
  • rivaroxaban (Xarelto®)
  • apixaban (Eliquis®)
  • edoxaban (Savaysa® [Lixiana® in Europe, Japan, elsewhere])

* Strong evidence
** Limited evidence

Typical Patient

No need to discontinue medication; use local measures to control bleeding

Patients with Higher Risk of Bleeding

Any suggested modification to the medication regimen prior to dental surgery should be done in consultation with and on advice of the patient’s physician

  • Introduction
  • Evidence: Target-Specific Oral Anticoagulants
  • Evidence: Warfarin and Antiplatelet Agents
  • References
  • Summary
  • Additional ADA Resources
  • Other Resources

Prepared by: Center for Science Information, ADA Science Institute
Last Updated: October 22, 2015


Content on is for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ADA is not responsible for information on external websites linked to this website